Eirik Søfteland

Empagliflozin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Linagliptin and Metformin: A 24-Week Randomized, Double-Blind, Parallel-Group Trial

Eirik Søfteland, Juris J. Meier, Bente Vangen et al. · Diabetes Care · 2016 · 130 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Safety and efficacy of ghrelin agonist TZP-101 in relieving symptoms in patients with diabetic gastroparesis: a randomized, placebo-controlled study

Georg Dimcevski, John M. Wo, Per M. Hellström et al. · Neurogastroenterology & Motility · 2010 · 113 citations

Medicine, Pharmacology, Pharmacotherapy +12

Diabetic Autonomic Neuropathy Affects Symptom Generation and Brain-Gut Axis

Christina Brock, Eirik Søfteland, Veronica Gunterberg et al. · Diabetes Care · 2013 · 67 citations · Full text

Medicine, Neurology, Neuroscience +17

A safe and effective micro-choice based rehabilitation for patients with long COVID: results from a quasi-experimental study

Bente Frisk, Marte Jürgensen, Birgitte Espehaug et al. · Scientific Reports · 2023 · 48 citations · Full text

Medicine, Health Sciences, Rehabilitation Medicine +15

Altered Brain Microstructure Assessed by Diffusion Tensor Imaging in Patients With Diabetes and Gastrointestinal Symptoms

Jens Brøndum Frøkjær, Lars W. Andersen, Christina Brock et al. · Diabetes Care · 2012 · 42 citations · Full text

Medicine, Neurobiology, Neuroscience +17